-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Ironwood Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2024.
- Ironwood Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 160M shares, a 14.3% decline year-over-year.
- Ironwood Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 155M shares, a 16.6% decline from 2022.
- Ironwood Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 186M shares, a 13.3% increase from 2021.
- Ironwood Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 164M shares, a 2.34% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)